Procambarus clarkii strain Jiangsu linkage group LG41, ASM2042438v2, whole genome shotgun sequence.
Procambarus clarkii (red swamp crayfish)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Astacidea; Astacoidea; Cambaridae; Procambarus.
A chromosome-level reference genome of red swamp crayfish Procambarus clarkii provides insights into the gene families regarding growth or development in crustaceans
REFSEQ INFORMATION: The reference sequence is identical to\nCM035513.1.\nAssembly name: ASM2042438v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Freshwater Fisheries Research\nInstitute of Jiangsu Province, Nanjing 210017, China on 2021/10/12.\nThe original whole-genome shotgun project has the accession\nJAIWQB000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Freshwater Fisheries Research Institute\n of Jiangsu Province, Nanjing 210017,\n China\nAssembly Method :: LACHESIS v. may-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100.0x\nSequencing Technology :: PacBio RS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Procambarus clarkii Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
hepatitis A virus cellular receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC123764691, transcript variant X4
uncharacterized LOC123764691, transcript variant X14
uncharacterized LOC123764691, transcript variant X13
uncharacterized LOC123764691, transcript variant X11
uncharacterized LOC123764691, transcript variant X9
uncharacterized LOC123764691, transcript variant X8
uncharacterized LOC123764691, transcript variant X12
uncharacterized LOC123764691, transcript variant X10
uncharacterized LOC123764691, transcript variant X7
uncharacterized LOC123764691, transcript variant X6
uncharacterized LOC123764691, transcript variant X1
uncharacterized LOC123764691, transcript variant X2
uncharacterized LOC123764691, transcript variant X3
uncharacterized LOC123764691, transcript variant X5
uncharacterized protein LOC123764691 isoform X2
uncharacterized protein LOC123764691 isoform X12
uncharacterized protein LOC123764691 isoform X11
uncharacterized protein LOC123764691 isoform X10
uncharacterized protein LOC123764691 isoform X9
uncharacterized protein LOC123764691 isoform X8
uncharacterized protein LOC123764691 isoform X7
uncharacterized protein LOC123764691 isoform X6
uncharacterized protein LOC123764691 isoform X5
uncharacterized protein LOC123764691 isoform X4
uncharacterized protein LOC123764691 isoform X1
uncharacterized protein LOC123764691 isoform X3
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X18
uncharacterized PE-PGRS family protein PE_PGRS10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X17
microtubule-associated serine/threonine-protein kinase 3-like isoform X16
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X15
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X16
microtubule-associated serine/threonine-protein kinase 3-like isoform X14
microtubule-associated serine/threonine-protein kinase 3-like isoform X15
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X10
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X11
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X1
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X6
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X3
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X8
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X5
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X7
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X4
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X22
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X9
microtubule-associated serine/threonine-protein kinase 3-like isoform X1
microtubule-associated serine/threonine-protein kinase 3-like isoform X5
microtubule-associated serine/threonine-protein kinase 3-like isoform X2
microtubule-associated serine/threonine-protein kinase 3-like isoform X6
microtubule-associated serine/threonine-protein kinase 3-like isoform X3
microtubule-associated serine/threonine-protein kinase 3-like isoform X7
microtubule-associated serine/threonine-protein kinase 3-like isoform X8
microtubule-associated serine/threonine-protein kinase 3-like isoform X10
microtubule-associated serine/threonine-protein kinase 3-like isoform X11
microtubule-associated serine/threonine-protein kinase 3-like isoform X4
microtubule-associated serine/threonine-protein kinase 3-like isoform X21
microtubule-associated serine/threonine-protein kinase 3-like isoform X9
microtubule-associated serine/threonine-protein kinase 3-like isoform X17
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X12
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X13
microtubule-associated serine/threonine-protein kinase 3-like isoform X12
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X20
microtubule-associated serine/threonine-protein kinase 3-like isoform X19
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X19
microtubule-associated serine/threonine-protein kinase 3-like isoform X18
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X14
microtubule-associated serine/threonine-protein kinase 3-like, transcript variant X21
microtubule-associated serine/threonine-protein kinase 3-like isoform X13
microtubule-associated serine/threonine-protein kinase 3-like isoform X20
uncharacterized LOC123764904, transcript variant X3
uncharacterized LOC123764904, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123764904, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC123764693, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123764693, transcript variant X2
protein C19orf12 homolog, transcript variant X3
protein C19orf12 homolog, transcript variant X2
protein C19orf12 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol phosphatase PTPRQ-like
protogenin A-like, transcript variant X8
protogenin A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
protogenin A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
protogenin A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
protogenin A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
protogenin A-like, transcript variant X5
protogenin A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
tyrosine-protein phosphatase Lar-like isoform X1
tyrosine-protein phosphatase Lar-like isoform X2
collagen alpha-1(XX) chain-like isoform X3
protogenin A-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
peptidyl-tRNA hydrolase ICT1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
phosphatidylinositol phosphatase PTPRQ-like, transcript variant X2
phosphatidylinositol phosphatase PTPRQ-like, transcript variant X1
phosphatidylinositol phosphatase PTPRQ-like isoform X2
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X1
uncharacterized LOC123764705, transcript variant X1
uncharacterized LOC123764705, transcript variant X4
uncharacterized LOC123764705, transcript variant X5
uncharacterized LOC123764705, transcript variant X2
uncharacterized LOC123764705, transcript variant X3
uncharacterized protein LOC123764705 isoform X1
uncharacterized protein LOC123764705 isoform X2
uncharacterized protein LOC123764705 isoform X3
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like, transcript variant X3
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like, transcript variant X2
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like, transcript variant X1
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like isoform X3
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like isoform X2
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like isoform X1
zinc finger FYVE domain-containing protein 1-like, transcript variant X6
zinc finger FYVE domain-containing protein 1-like, transcript variant X9
zinc finger FYVE domain-containing protein 1-like, transcript variant X4
zinc finger FYVE domain-containing protein 1-like, transcript variant X1
zinc finger FYVE domain-containing protein 1-like, transcript variant X5
zinc finger FYVE domain-containing protein 1-like, transcript variant X3
zinc finger FYVE domain-containing protein 1-like, transcript variant X8
zinc finger FYVE domain-containing protein 1-like, transcript variant X7
zinc finger FYVE domain-containing protein 1-like, transcript variant X2
zinc finger FYVE domain-containing protein 1-like isoform X3
zinc finger FYVE domain-containing protein 1-like isoform X1
zinc finger FYVE domain-containing protein 1-like isoform X2
RNA-binding motif protein, X-linked 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 109 samples with support for all annotated introns
uncharacterized LOC123764709, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123764709, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC123764709 isoform X1
uncharacterized protein LOC123764709 isoform X2
DNA-directed RNA polymerase III subunit RPC2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 87 samples with support for all annotated introns
RING finger protein 212B-like, transcript variant X2
RING finger protein 212B-like, transcript variant X1
RING finger protein 212B-like isoform X2
probable E3 SUMO-protein ligase RNF212 isoform X1
RING finger protein 212B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3-like isoform X2
E3 ubiquitin-protein ligase Ubr3-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cytochrome c oxidase assembly factor 7 homolog, transcript variant X1
cytochrome c oxidase assembly factor 7 homolog, transcript variant X2
cytochrome c oxidase assembly factor 7 homolog
E3 ubiquitin-protein ligase UBR4-like, transcript variant X1
E3 ubiquitin-protein ligase UBR4-like, transcript variant X3
E3 ubiquitin-protein ligase UBR4-like, transcript variant X4
E3 ubiquitin-protein ligase UBR4-like, transcript variant X2
E3 ubiquitin-protein ligase UBR4-like, transcript variant X6
E3 ubiquitin-protein ligase UBR4-like, transcript variant X7
E3 ubiquitin-protein ligase UBR4-like, transcript variant X8
E3 ubiquitin-protein ligase UBR4-like, transcript variant X5
E3 ubiquitin-protein ligase UBR4-like isoform X1
E3 ubiquitin-protein ligase UBR4-like isoform X3
E3 ubiquitin-protein ligase UBR4-like isoform X4
E3 ubiquitin-protein ligase UBR4-like isoform X2
E3 ubiquitin-protein ligase UBR4-like isoform X6
E3 ubiquitin-protein ligase UBR4-like isoform X8
E3 ubiquitin-protein ligase UBR4-like isoform X7
E3 ubiquitin-protein ligase UBR4-like isoform X5
protein-lysine N-methyltransferase EEF2KMT-like, transcript variant X1
protein-lysine N-methyltransferase EEF2KMT-like, transcript variant X2
protein-lysine N-methyltransferase EEF2KMT-like, transcript variant X3
protein-lysine N-methyltransferase EEF2KMT-like
ATP synthase subunit beta, mitochondrial
uncharacterized LOC123764719, transcript variant X5
uncharacterized LOC123764719, transcript variant X2
uncharacterized LOC123764719, transcript variant X4
uncharacterized LOC123764719, transcript variant X1
uncharacterized LOC123764719, transcript variant X6
uncharacterized LOC123764719, transcript variant X3
1-acyl-sn-glycerol-3-phosphate acyltransferase delta-like
S-methyl-5'-thioadenosine phosphorylase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
hydroxyacid-oxoacid transhydrogenase, mitochondrial-like, transcript variant X2
hydroxyacid-oxoacid transhydrogenase, mitochondrial-like, transcript variant X1
hydroxyacid-oxoacid transhydrogenase, mitochondrial-like isoform X2
hydroxyacid-oxoacid transhydrogenase, mitochondrial-like isoform X1
group XIIB secretory phospholipase A2-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
extracellular sulfatase Sulf-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
extracellular sulfatase Sulf-1-like, transcript variant X1
extracellular sulfatase Sulf-1-like, transcript variant X2
extracellular sulfatase Sulf-1-like, transcript variant X3
uncharacterized protein LOC123764728 isoform X1
uncharacterized protein LOC123764728 isoform X2
uncharacterized protein LOC123764728 isoform X3
extracellular sulfatase Sulf-1-like isoform X4
palmitoyl-protein thioesterase ABHD10, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
palmitoyl-protein thioesterase ABHD10, mitochondrial-like, transcript variant X3
palmitoyl-protein thioesterase ABHD10, mitochondrial-like, transcript variant X1
palmitoyl-protein thioesterase ABHD10, mitochondrial-like isoform X1
uncharacterized protein LOC123764732 isoform X3
palmitoyl-protein thioesterase ABHD10, mitochondrial-like isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC123764730, transcript variant X9
uncharacterized LOC123764730, transcript variant X3
uncharacterized LOC123764730, transcript variant X1
uncharacterized protein LOC123764730 isoform X1
transmembrane protein 185A-like, transcript variant X3
transmembrane protein 185A-like, transcript variant X2
transmembrane protein 185A-like, transcript variant X1
uncharacterized LOC123764730, transcript variant X4
uncharacterized LOC123764730, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123764730, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC123764730, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123764730, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123764730, transcript variant X5
uncharacterized protein LOC123764730 isoform X2
uncharacterized protein LOC123764730 isoform X3
adenosine 5'-monophosphoramidase HINT1-like
similar to RNA sequence (same species):INSD:GBEV01035868.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 656 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 656 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
protein-tyrosine sulfotransferase 2-like, transcript variant X2
protein-tyrosine sulfotransferase 2-like, transcript variant X1
protein-tyrosine sulfotransferase 2-like isoform X2
protein-tyrosine sulfotransferase 2-like isoform X1
netrin receptor unc-40-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
netrin receptor unc-40-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
phosphatidylinositol phosphatase PTPRQ-like, transcript variant X3
phosphatidylinositol phosphatase PTPRQ-like isoform X1
phosphatidylinositol phosphatase PTPRQ-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized abhydrolase domain-containing protein DDB_G0269086-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
60S ribosomal protein L9-like, transcript variant X1
60S ribosomal protein L9-like, transcript variant X2
tether containing UBX domain for GLUT4-like, transcript variant X2
tether containing UBX domain for GLUT4-like, transcript variant X1
tether containing UBX domain for GLUT4-like isoform X1
tether containing UBX domain for GLUT4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB2
CAP-Gly domain-containing linker protein 1-like, transcript variant X10
CAP-Gly domain-containing linker protein 1-like, transcript variant X11
CAP-Gly domain-containing linker protein 1-like, transcript variant X8
CAP-Gly domain-containing linker protein 1-like, transcript variant X1
CAP-Gly domain-containing linker protein 1-like, transcript variant X5
CAP-Gly domain-containing linker protein 1-like, transcript variant X3
CAP-Gly domain-containing linker protein 1-like, transcript variant X7
CAP-Gly domain-containing linker protein 1-like, transcript variant X6
CAP-Gly domain-containing linker protein 1-like, transcript variant X2
CAP-Gly domain-containing linker protein 1-like isoform X1
CAP-Gly domain-containing linker protein 1-like isoform X2
CAP-Gly domain-containing linker protein 1-like isoform X5
CAP-Gly domain-containing linker protein 1-like isoform X3
CAP-Gly domain-containing linker protein 1-like isoform X7
CAP-Gly domain-containing linker protein 1-like isoform X8
CAP-Gly domain-containing linker protein 1-like isoform X6
CAP-Gly domain-containing linker protein 1-like isoform X10
CAP-Gly domain-containing linker protein 1-like isoform X11
CAP-Gly domain-containing linker protein 1-like, transcript variant X4
CAP-Gly domain-containing linker protein 1-like isoform X4
CAP-Gly domain-containing linker protein 1-like, transcript variant X9
CAP-Gly domain-containing linker protein 1-like isoform X9
CAP-Gly domain-containing linker protein 1-like, transcript variant X12
CAP-Gly domain-containing linker protein 1-like, transcript variant X13
CAP-Gly domain-containing linker protein 1-like isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat protein 4-like, transcript variant X3
tetratricopeptide repeat protein 4-like, transcript variant X2
tetratricopeptide repeat protein 4-like, transcript variant X1
tetratricopeptide repeat protein 4-like isoform X2
tetratricopeptide repeat protein 4-like isoform X1
elongation of very long chain fatty acids protein-like, transcript variant X1
elongation of very long chain fatty acids protein-like, transcript variant X2
elongation of very long chain fatty acids protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X1
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X2
elongation of very long chain fatty acids protein AAEL008004-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
paternally-expressed gene 3 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
elongation of very long chain fatty acids protein AAEL008004-like isoform X1
elongation of very long chain fatty acids protein AAEL008004-like isoform X2
synaptic vesicle glycoprotein 2C-like, transcript variant X4
synaptic vesicle glycoprotein 2C-like, transcript variant X1
synaptic vesicle glycoprotein 2C-like, transcript variant X3
synaptic vesicle glycoprotein 2C-like, transcript variant X2
synaptic vesicle glycoprotein 2C-like isoform X3
synaptic vesicle glycoprotein 2C-like isoform X1
synaptic vesicle glycoprotein 2B-like isoform X2
60S ribosomal protein L31-like, transcript variant X1
60S ribosomal protein L31-like, transcript variant X2
condensin complex subunit 2-like, transcript variant X3
condensin complex subunit 2-like, transcript variant X1
condensin complex subunit 2-like, transcript variant X2
metabotropic glutamate receptor 2-like, transcript variant X1
metabotropic glutamate receptor 2-like, transcript variant X2
metabotropic glutamate receptor 2-like isoform X1
uncharacterized protein LOC123764761 isoform X2
uncharacterized LOC123764762, transcript variant X2
uncharacterized LOC123764762, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC123764762, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
40S ribosomal protein S12-like, transcript variant X1
40S ribosomal protein S12-like, transcript variant X2
isobutyryl-CoA dehydrogenase, mitochondrial-like
centromere protein X-like, transcript variant X2
centromere protein X-like, transcript variant X1
uncharacterized LOC123764767, transcript variant X1
uncharacterized LOC123764767, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC123764767 isoform X1
uncharacterized protein LOC123764767 isoform X2
uncharacterized LOC123764768, transcript variant X2
uncharacterized LOC123764768, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123764768, transcript variant X4
uncharacterized LOC123764768, transcript variant X5
uncharacterized LOC123764768, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
failed axon connections-like, transcript variant X1
failed axon connections-like, transcript variant X2
failed axon connections-like, transcript variant X3
uncharacterized LOC123764771, transcript variant X1
uncharacterized LOC123764771, transcript variant X4
uncharacterized protein LOC123764771 isoform X1
uncharacterized LOC123764771, transcript variant X2
uncharacterized LOC123764771, transcript variant X3
uncharacterized protein LOC123764771 isoform X2
uncharacterized protein LOC123764771 isoform X3
multiple epidermal growth factor-like domains protein 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6, transcript variant X2
multiple epidermal growth factor-like domains protein 6 isoform X1
multiple epidermal growth factor-like domains protein 6 isoform X2
multiple epidermal growth factor-like domains protein 6, transcript variant X3
uncharacterized LOC123764774, transcript variant X2
uncharacterized protein LOC123764774 isoform X2
uncharacterized LOC123764774, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein LOC123764774 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
multiple epidermal growth factor-like domains protein 6 isoform X3
multiple epidermal growth factor-like domains protein 6, transcript variant X4
multiple epidermal growth factor-like domains protein 6 isoform X4
uncharacterized LOC123764776, transcript variant X1
uncharacterized LOC123764776, transcript variant X2
protogenin B-like, transcript variant X5
protogenin B-like, transcript variant X3
protogenin B-like, transcript variant X4
protogenin B-like, transcript variant X2
protogenin B-like, transcript variant X1
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
low affinity immunoglobulin epsilon Fc receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X3
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X2
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X6
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X1
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X4
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like, transcript variant X5
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like isoform X1
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform-like isoform X2
nicotinamide riboside kinase 1-like, transcript variant X2
nicotinamide riboside kinase 1-like, transcript variant X1
nicotinamide riboside kinase 1-like, transcript variant X3
nicotinamide riboside kinase 1-like isoform X1
nicotinamide riboside kinase 1-like isoform X2
nicotinamide riboside kinase 1-like isoform X3
N6-adenosine-methyltransferase non-catalytic subunit-like, transcript variant X3
N6-adenosine-methyltransferase non-catalytic subunit-like, transcript variant X4
N6-adenosine-methyltransferase non-catalytic subunit-like, transcript variant X2
N6-adenosine-methyltransferase non-catalytic subunit-like, transcript variant X1
N6-adenosine-methyltransferase non-catalytic subunit-like, transcript variant X5
N6-adenosine-methyltransferase non-catalytic subunit-like isoform X1
N6-adenosine-methyltransferase non-catalytic subunit-like isoform X2
UDP-glucosyltransferase 2-like, transcript variant X2
UDP-glucosyltransferase 2-like, transcript variant X1
UDP-glycosyltransferase UGT5-like isoform X2
UDP-glucosyltransferase 2-like isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
serine-enriched protein-like, transcript variant X1
serine-enriched protein-like, transcript variant X2
serine-enriched protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
non-classical arabinogalactan protein 31-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase SMYD3-like, transcript variant X4
histone-lysine N-methyltransferase SMYD3-like, transcript variant X3
histone-lysine N-methyltransferase SMYD3-like, transcript variant X1
histone-lysine N-methyltransferase SMYD3-like isoform X4
histone-lysine N-methyltransferase SMYD3-like isoform X3
histone-lysine N-methyltransferase SMYD3-like isoform X1
histone-lysine N-methyltransferase SMYD3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
histone-lysine N-methyltransferase SMYD3-like isoform X2
protein NipSnap homolog 3A-like, transcript variant X1
protein NipSnap homolog 3A-like, transcript variant X2
protein NipSnap homolog 3A-like isoform X2
protein NipSnap homolog 3A-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
ADAM 17-like protease, transcript variant X2
ADAM 17-like protease, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
L-lactate dehydrogenase-like, transcript variant X1
L-lactate dehydrogenase-like, transcript variant X2
L-lactate dehydrogenase-like, transcript variant X3
L-lactate dehydrogenase-like, transcript variant X4
neuropeptide Y receptor type 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
neuropeptide Y receptor type 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
neuropeptide Y receptor type 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
neuropeptide Y receptor type 2-like isoform X1
neuropeptide Y receptor type 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
serine/arginine repetitive matrix protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/arginine repetitive matrix protein 1-like, transcript variant X3
serine/arginine repetitive matrix protein 1-like, transcript variant X2
serine/arginine repetitive matrix protein 1-like isoform X1
serine/arginine repetitive matrix protein 1-like isoform X2
protein stoned-B-like, transcript variant X1
protein stoned-B-like, transcript variant X2
type-1 angiotensin II receptor-associated protein-like
adenylate cyclase, germination specific-like
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X2
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X9
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X5
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X4
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X8
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X10
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X6
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X1
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X3
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X11
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X7
E3 ubiquitin-protein ligase RNF113A-like isoform X1
E3 ubiquitin-protein ligase RNF113A-like isoform X2
E3 ubiquitin-protein ligase RNF113A-like isoform X3
calmodulin-binding transcription activator 2-like, transcript variant X4
calmodulin-binding transcription activator 2-like, transcript variant X5
calmodulin-binding transcription activator 2-like, transcript variant X1
calmodulin-binding transcription activator 2-like, transcript variant X6
calmodulin-binding transcription activator 2-like, transcript variant X2
calmodulin-binding transcription activator 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calmodulin-binding transcription activator 1-like isoform X2
calmodulin-binding transcription activator 2-like isoform X1
calmodulin-binding transcription activator 2-like isoform X4
calmodulin-binding transcription activator 2-like isoform X6
uncharacterized protein LOC123764803 isoform X5
calmodulin-binding transcription activator 2-like isoform X3
calmodulin-binding transcription activator 2-like, transcript variant X7
calmodulin-binding transcription activator 2-like isoform X7
anti-lipopolysaccharide factor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
anti-lipopolysaccharide factor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
anti-lipopolysaccharide factor-like, transcript variant X2
anti-lipopolysaccharide factor-like, transcript variant X3
anti-lipopolysaccharide factor-like isoform X1
anti-lipopolysaccharide factor-like, transcript variant X6
anti-lipopolysaccharide factor-like, transcript variant X5
anti-lipopolysaccharide factor-like isoform X2
basic helix-loop-helix transcription factor amos-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD9-like
pancreas transcription factor 1 subunit alpha-like
T-cell acute lymphocytic leukemia protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycine-rich cell wall structural protein-like
tigger transposable element-derived protein 1-like
guanine nucleotide exchange factor subunit RIC1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized serine-rich protein C215.13-like
basic salivary proline-rich protein 1-like
mediator of DNA damage checkpoint protein 1-like
uncharacterized LOC123764809, transcript variant X2
uncharacterized LOC123764809, transcript variant X1
uncharacterized protein LOC123764809 isoform X2
uncharacterized protein LOC123764809 isoform X1
high mobility group nucleosome-binding domain-containing protein 5-like
DNA-dependent protein kinase catalytic subunit-like
snake venom metalloprotease inhibitor 02D01-like
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like
biotin carboxyl carrier protein of acetyl-CoA carboxylase, chloroplastic-like
serine/threonine-protein kinase OSR1-like, transcript variant X2
serine/threonine-protein kinase OSR1-like, transcript variant X1
serine/threonine-protein kinase OSR1-like, transcript variant X5
serine/threonine-protein kinase OSR1-like, transcript variant X4
serine/threonine-protein kinase OSR1-like, transcript variant X3
serine/threonine-protein kinase OSR1-like, transcript variant X6
serine/threonine-protein kinase OSR1-like isoform X5
serine/threonine-protein kinase OSR1-like isoform X4
serine/threonine-protein kinase OSR1-like isoform X2
serine/threonine-protein kinase OSR1-like isoform X1
serine/threonine-protein kinase OSR1-like isoform X3
serine/threonine-protein kinase OSR1-like isoform X6
GDP-D-glucose phosphorylase 1-like, transcript variant X2
GDP-D-glucose phosphorylase 1-like isoform X1
GDP-D-glucose phosphorylase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1-like isoform X2
RING finger and SPRY domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 15-like
SH3 domain-containing protein C23A1.17-like
uncharacterized protein DDB_G0290685-like
DNA-directed RNA polymerase II subunit RPB1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
probable methyltransferase-like protein 25, transcript variant X1
probable methyltransferase-like protein 25 isoform X1
probable methyltransferase-like protein 25, transcript variant X2
probable methyltransferase-like protein 25 isoform X2
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like
putative uncharacterized protein ENSP00000383309
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X2
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X3
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X1
uncharacterized protein F13E9.13, mitochondrial-like isoform X1
uncharacterized protein F13E9.13, mitochondrial-like isoform X3
uncharacterized protein F13E9.13, mitochondrial-like isoform X2
histone-arginine methyltransferase CARMER-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histone-arginine methyltransferase CARMER-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
histone-arginine methyltransferase CARMER-like isoform X2
histone-arginine methyltransferase CARMER-like isoform X1
spermine synthase-like, transcript variant X1
spermine synthase-like, transcript variant X4
spermine synthase-like, transcript variant X3
spermine synthase-like, transcript variant X2
structural maintenance of chromosomes protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X2
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X1
mitochondrial inner membrane protease ATP23 homolog, transcript variant X1
mitochondrial inner membrane protease ATP23 homolog, transcript variant X2
mitochondrial inner membrane protease ATP23 homolog isoform X1
mitochondrial inner membrane protease ATP23 homolog isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123764833, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123764833, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized protein LOC123764833 isoform X1
uncharacterized protein LOC123764833 isoform X2
golgin subfamily A member 6-like protein 7
pollen-specific leucine-rich repeat extensin-like protein 2